Skip to content

Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure

Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07019636
Acronym
T-REX
Enrollment
314
Registered
2025-06-13
Start date
2026-07-15
Completion date
2028-10-15
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weaning From Mechanical Ventilation, Extubation

Keywords

Weaning, Mechanical ventilation, Extubation

Brief summary

This randomized controlled open label trial aims at comparing a weaning strategy including a spontaneous breathing trial as a prerequisite for extubation to a weaning strategy without a spontaneous breathing trial (direct extubation) in patients with readiness to be weaned criteria and considered at low risk of extubation failure. The main endpoint will be the proportion of patients successfully extubated within the 24 hours after randomization as compared to extubation after a successful spontaneous breathing trial (SBT).

Detailed description

Weaning from mechanical ventilation is a critical step in the course on an ICU stay. Separation from the ventilator should be done at the earliest possible time, but extubation failure is an adverse event that should be avoided. The most common decision-making strategy regarding weaning and extubation is to combine a daily assessment of the patient's "readiness to wean" and a spontaneous breathing trial before to extubate. The result of the SBT (passed of failed) is often viewed as a "go - no go" indicator of whether or not patients are ready for extubation, but daily practice indicates that the assessment of the SBT is subjective with a frequent natural tendency for clinicians to keep their patients on the 'safe' side, i.e., considering them as not being ready for extubation. However, the results of the SBT should be interpreted based on the pre-test probability. Conducting a SBT in patients while the pre-test probability of success is high will result in false negatives which are likely to delay the decision of extubation. In addition, a pointless SBT may expose patients to anxiety, air hunger and dyspnea which are poorly detected by caregivers. The hypothesis of the present project is that in patients who are at low risk of extubation failure, a SBT is useless and once readiness to wean criteria are met, direct extubation would increase the proportion of patients successfully extubated within the 24 hours after randomization as compared to extubation after a successful SBT.

Interventions

PROCEDUREWeaning strategy with direct extubation (no spontaneous breathing trial)

Patients will be extubated within the 60 minutes following randomization

PROCEDUREWeaning strategy with extubation only after a successful spontaneous breathing

Patients will undergo a spontaneous breathing trial and will be extubated only in case of successful spontaneous breathing

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age older than 18 years and \< 65 years old * Nasal or oral intubation longer than 24 hours and less than 4 days * Satisfaction to each following weaning readiness criteria: 1. Respiratory rate \< 35 cycles per minute 2. SpO2 \>90% with FiO2\<40% and PEEP\<8 cmH2O 3. RASS score between -2 and +2 with low level or no sedatives 4. No need or low doses of vasopressors 5. Adequate cough * Inform consent by patient or legal representative or the close relative or emergency inclusion procedure.

Exclusion criteria

* Risk factor for extubation failure as defined by any of the following criteria: * Chronic cardiac disease (left ejection fraction below 45%, documented history of cardiogenic pulmonary edema, permanent atrial fibrillation). * Chronic respiratory disease (severe COPD, documented restricted lung disease or obesity-hypoventilation syndrome) * Body mass index \> 30 kg/m2 * Airway patency problems, including high risk of developing laryngeal edema, inability to deal with respiratory secretions, brain injury, documented swallowing disorders * Tracheostomy * Underlying chronic neuromuscular disease * Do not resuscitate orders * Pregnant or lacting woman * Patient under guardianship * Patient without healthcare insurance * Refusal to participate and sign the written consent * Patients with traumatic brain injury * Post surgery patients * Patients included in another interventional trial that may have an impact on the evaluation criteria of the present study * Patient under AME

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients extubated within the 24 hours after randomization and who will remain free from mechanical ventilation until 72 hours.From Day 1 to Day 3The rate of patients extubated within the 24 hours after randomization and who will remain free from mechanical ventilation until 72 hours.

Secondary

MeasureTime frameDescription
Occurrence of post extubation acute respiratory failureWithin 28 days after randomizationRate of post extubation acute respiratory failure defined by the persistence of more than 30 minutes of at least two predefined criteria
Occurrence of reintubationWithin 28 days after randomizationRate of of reintubation with predefined criteria
Unplanned use of non-invasive ventilation or high flow nasal oxygenWithin 28 days after randomizationRate of unplanned use of non-invasive ventilation or high flow nasal oxygen
Duration of weaning process from randomization until successful extubationWithin 28 days after randomizationNumber of days from randomization until successful extubation
Total duration of invasive mechanical ventilation from intubation until successful extubationWithin 28 days after randomizationTotal number of days of invasive mechanical ventilation from intubation until successful extubation
Number of Ventilator Free Days between randomization until Day 28Within 28 days after randomizationNumber of days without the ventilator and alive from randomization until Day 28
Occurrence of ventilator acquired pneumoniaWithin 28 days after randomizationVentilator acquired pneumonia will be defined by quantitative distal bronchoalveolar lavage cultures growing ≥104cfu/mL
Length of stay in the ICU and hospital stayWithin 28 days after randomizationNumber of days in the ICU and in the hospital
ICU and hospital mortalityWithin 28 days after randomizationProportion of patients who died in the ICU and in the hospital
Day 28 mortalityWithin 28 days after randomizationRate of patients who died at day 28 after randomization
Cumulative incidence of successful extubation over timeWithin 28 days after randomizationProbability of being successfully extubated from randomization until day 28
Duration between randomization and SBT trialWithin 28 days after randomizationThe time between randomization and the onset of the SBT, minutes
Barriers to extubation: logistical, timing, family or patient.Within 28 days after randomizationOpen
Duration between extubation decision and extubationWithin 28 days after randomizationTime between extubation decision and extubation, minutes

Countries

France

Contacts

CONTACTMartin DRES, Pr
martin.dres@aphp.fr01 42 16 77 97
PRINCIPAL_INVESTIGATORMartin DRES, Pr

Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026